+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A Phase I Study of Concurrent Capecitabine and Intensity Modulated Radiation Therapy(IMRT) as Adjuvant Treatment for Locally Advanced Gastric Cancer



A Phase I Study of Concurrent Capecitabine and Intensity Modulated Radiation Therapy(IMRT) as Adjuvant Treatment for Locally Advanced Gastric Cancer



International Journal of Radiation Oncology*biology*physics 84(3): S315-S316




(PDF emailed within 0-6 h: $19.90)

Accession: 064158327

Download citation: RISBibTeXText

DOI: 10.1016/j.ijrobp.2012.07.827


Related references

Intensity Modulated Radiation Therapy With S-1 Versus Capecitabine as Adjuvant Treatment for Locally Advanced Gastric Cancer. International Journal of Radiation Oncology*biology*physics 93(3): E133-E134, 2015

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Radiation Oncology 10(): 57-57, 2016

Phase I study of capecitabine combined with weekly carboplatin and intensity modulated radiation therapy (IMRT) for treatment of locally advanced squamous cell carcinomas of the head and neck (HNSCC). Journal of Clinical Oncology 24(18_suppl): 15522-15522, 2016

Phase I trial of preoperative hypofractionated intensity modulated radiation therapy (IMRT) with incorporated boost and oral capecitabine in locally advanced rectal cancer (vol 67, pg 651, 2007). International Journal of Radiation Oncology Biology Physics 69(1): 320, 2007

Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial. International Journal of Radiation Oncology, Biology, Physics 83(2): 587-593, 2012

Phase II Study of Irinotecan and Capecitabine Concurrent With Intensity Modulated Radiation Therapy in the Treatment of Recurrent Rectal Cancer. International Journal of Radiation Oncology*biology*physics 84(3): S194-S195, 2012

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics 93(1): 29-36, 2015

Hypothyroidism as a consequence of intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC). Journal of Clinical Oncology 26(15_suppl): 6048-6048, 2016

Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. International Journal of Radiation Oncology, Biology, Physics 91(1): 116-123, 2015

Intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer(LAHNC): Feasibility, technique, and toxicities. Journal of Clinical Oncology 23(16_suppl): 5536-5536, 2016

Phase 1 Dose Escalation Study of Accelerated Fractionation and Concurrent Chemotherapy Using Intensity Modulated Radiation Therapy for Locally Advanced Lung Cancer. International Journal of Radiation Oncology*biology*physics 90(1): S213-S214, 2014

Prospective phase I study of capecitabine and oxaliplatin concurrent with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma, and retrospective comparison to concurrent 5-fluorouracil/radiation and gemcitabine/radiation. Journal of Gastrointestinal Cancer 43(2): 258-266, 2012

Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC). Oral Oncology 50(10): 947-955, 2015

Clinical study on concurrent and sequential therapy of intensity modulated radiation therapy (IMRT) combined with NP regimen chemotherapy in the treatment of middle and advanced non-small cell lung cancer. Chinese-German Journal of Clinical Oncology 6(1): 2-4, 2007

RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer. Journal of Clinical Oncology 26(15_suppl): 4021-4021, 2016